Thrombohemorrhagic Complications of COVID-19

V

Volgograd State Medical University

Status

Active, not recruiting

Conditions

COVID-19 (Coronavirus Disease 2019)

Treatments

Diagnostic Test: Prevention algorithm

Study type

Interventional

Funder types

Other

Identifiers

NCT06223945
12/2024/01/12

Details and patient eligibility

About

The nature of the planned study: The topic is of an applied nature and is aimed at improving the results of comprehensive treatment of patients with COVID-19, the course of whose disease was complicated by thrombotic or hemorrhagic catastrophes. It is planned to analyze the results of treatment of this category of patients based on the work of several centers that provided surgical care to patients with COVID-19 during the pandemic (8 cities). As a result of the analysis, it is planned to develop algorithms for the prevention and treatment of thrombotic and hemorrhagic complications in patients with COVID-19. The proposed study will be multicenter, cohort, retrospective. The purpose of the study: Improvement of treatment results in COVID-19 patients with thrombotic or hemorrhagic complications Scientific novelty: For the first time, as a result of a multicenter study, it is expected to identify the most effective approach to the treatment and prevention of thrombotic and hemorrhagic complications in patients with COVID-19. For the first time, it is planned to develop and put into practice algorithms for the application of the most effective methods of treatment and prevention of thrombohemorrhagic complications of COVID-19.

Enrollment

1 estimated patient

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with thrombohemorrhagic complications who were treated in a covid hospital

Exclusion criteria

  • Cancer patients
  • Patients who had thrombohemorrhagic disorders before admission to the hospital
  • Pregnant women
  • Patients receiving routine anticoagulant and antiplatelet therapy before admission to the hospital

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1 participants in 2 patient groups

Thrombotic and hemorrhagic complications of COVID-19
Active Comparator group
Treatment:
Diagnostic Test: Prevention algorithm
Prevention of thrombohemorrhagic complications in COVID-19
Active Comparator group
Treatment:
Diagnostic Test: Prevention algorithm

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems